These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24374222)

  • 1. The evaluation of the biomedical effectiveness of poly(amido)amine dendrimers generation 4.0 as a drug and as drug carriers: a systematic review and meta-analysis.
    Jędrych M; Borowska K; Galus R; Jodłowska-Jędrych B
    Int J Pharm; 2014 Feb; 462(1-2):38-43. PubMed ID: 24374222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
    Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
    Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes.
    Muñoz AM; Fragoso-Vázquez MJ; Martel BP; Chávez-Blanco A; Dueñas-González A; R García-Sánchez J; Bello M; Romero-Castro A; Correa-Basurto J
    Anticancer Agents Med Chem; 2020; 20(15):1857-1872. PubMed ID: 32324521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? In the search for minimizing of the adverse effects of PAMAM administration.
    Labieniec-Watala M; Przygodzki T; Sebekova K; Watala C
    Int J Pharm; 2014 Apr; 464(1-2):152-67. PubMed ID: 24463003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(amido)amine dendrimers generation 4.0 (PAMAM G4) reduce blood hyperglycaemia and restore impaired blood-brain barrier permeability in streptozotocin diabetes in rats.
    Karolczak K; Rozalska S; Wieczorek M; Labieniec-Watala M; Watala C
    Int J Pharm; 2012 Oct; 436(1-2):508-18. PubMed ID: 22721855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mPEG-PAMAM-G4 nucleic acid nanocomplexes: enhanced stability, RNase protection, and activity of splice switching oligomer and poly I:C RNA.
    Reyes-Reveles J; Sedaghat-Herati R; Gilley DR; Schaeffer AM; Ghosh KC; Greene TD; Gann HE; Dowler WA; Kramer S; Dean JM; Delong RK
    Biomacromolecules; 2013 Nov; 14(11):4108-15. PubMed ID: 24164501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual observation and characterization of fluorescent poly(amido amine) dendrimer in film state.
    Saravanan G; Imae T
    J Nanosci Nanotechnol; 2011 Jun; 11(6):4838-45. PubMed ID: 21770112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAMAM G4 dendrimers lower high glucose but do not improve reduced survival in diabetic rats.
    Labieniec M; Ulicna O; Vancova O; Glowacki R; Sebekova K; Bald E; Gabryelak T; Watala C
    Int J Pharm; 2008 Nov; 364(1):142-9. PubMed ID: 18761397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(amido amine) dendrimers in oral delivery.
    Yellepeddi VK; Ghandehari H
    Tissue Barriers; 2016; 4(2):e1173773. PubMed ID: 27358755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions.
    Martínez-Muñoz A; Bello M; Romero-Castro A; Rodríguez-Fonseca RA; Rodrigues J; Sánchez-Espinosa VA; Correa-Basurto J
    J Mol Graph Model; 2017 Sep; 76():330-341. PubMed ID: 28759825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of 8-methoxypsoralene mediated by polyamidoamine dendrimer G2.5 and G3.5--in vitro and in vivo study.
    Borowska K; Wołowiec S; Głowniak K; Sieniawska E; Radej S
    Int J Pharm; 2012 Oct; 436(1-2):764-70. PubMed ID: 22884834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
    Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
    Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
    J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do the full-generation poly(amido)amine (PAMAM) dendrimers activate blood platelets? Activation of circulating platelets and formation of "fibrinogen aggregates" in the presence of polycations.
    Watala C; Karolczak K; Kassassir H; Talar M; Przygodzki T; Maczynska K; Labieniec-Watala M
    Int J Pharm; 2016 Apr; 503(1-2):247-61. PubMed ID: 26319628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations.
    Jain V; Maiti PK; Bharatam PV
    J Chem Phys; 2016 Sep; 145(12):124902. PubMed ID: 27782646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innovative in situ method of creating hybrid dendrimer nano-assembly: An efficient next generation dendritic platform for drug delivery.
    Singh MK; Kuncha M; Nayak VL; Sarma AVS; Kumar MJM; Chauhan AS; Sistla R
    Nanomedicine; 2019 Oct; 21():102043. PubMed ID: 31247312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin.
    Diaz C; Guzmán J; Jiménez VA; Alderete JB
    Pharm Dev Technol; 2018 Sep; 23(7):689-696. PubMed ID: 28368674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
    Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
    J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of poly(amido)amine dendrimers in prevention of early non-enzymatic modifications of biomacromolecules.
    Labieniec M; Watala C
    Biochimie; 2010 Oct; 92(10):1296-305. PubMed ID: 20542077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Methotrexate with Native and PEGylated PAMAM-G4 Dendrimers: Effect of the PEGylation Degree on the Drug-Loading Capacity and Preferential Binding Sites.
    Barraza LF; Jiménez VA; Alderete JB
    J Phys Chem B; 2017 Jan; 121(1):4-12. PubMed ID: 27982591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.